FOXO4-DRI × Tydes — lab test, September 2025
Janoshik Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 14.68 mg
147% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 3.7 mg using the measured mass, against 2.5 mg on the label — 47% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of FOX04-DRI (Proxofim) from Tydes, performed by Janoshik Labs on September 8, 2025. Reported purity: 99.235%. Net content: 14.68 mg against 10 mg labeled (147% of label). Tested content exceeds the labeled amount by 47%. Batch FOX10090225. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of FOXO4-DRI from Tydes
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| FOX15021926 | 10 Mar 2026 | Janoshik Labs | 99.724% | 98% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion